A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE 2 STUDY OF THE ERC-1671 (GLIOVAC) VACCINE IN COMBINATION WITH BEVACIZUMAB (BEV) IN RECURRENT GBM PATIENTS: SAFETY LEAD-IN ANALYSIS

被引：0

作者：

Bota, Daniela ^{[1
]}

Carrillo, Jose ^{[1
]}

Kong, Xiao-Tang ^{[1
]}

Fu, Dan ^{[1
]}

Chung, Jinah ^{[2
]}

Pretto, Chrystel ^{[3
]}

Strik, Ankie ^{[3
]}

Schijns, Virgil ^{[3
]}

Stathopoulos, Apostolos ^{[3
]}

机构：

[1] UC Irvine Med Ctr, Orange, CA USA

[2] UC Irvine Med Ctr, Irvine, CA USA

[3] ERC Belgium, Isnes, Belgium

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ATIM-20

引用

页码：22 / 22

页数：1

共 50 条

[11] Efficacy and safety of plecanatide in Chinese patients with functional constipation: A phase III randomized, double-blinded, placebo-controlled, multicenter trial [J].

Bai, Tao ;

Xu, Zhiyue ;

Jiang, Yueping ;

Zhao, Hong ;

Yan, Peng ;

Dai, Ning ;

Chen, Xi ;

Huang, Kunming ;

Cui, Jun ;

Xu, Min ;

Jia, Shujuan ;

Zhang, Juan ;

Liu, Side ;

Li, Xiaoqing ;

Ai, Yaowei ;

Zhang, Mingxin ;

Wu, Yongdong ;

Zhou, Weizhen ;

Zhao, Rong ;

Wu, Jianjun ;

Wang, Bangmao ;

Xu, Baohong ;

Ding, Xiangwu ;

Fang, Xiangming ;

Yang, Shaoqi ;

Ma, Yingcai ;

Zhou, Zhongyin ;

Lin, Lin ;

Chen, Huixin ;

Zhang, Heng ;

Zhu, Yin ;

Jiang, Bo ;

Zhang, Xiaolan ;

Wang, Xiaoyan ;

Zou, Duowu ;

Ye, Bin ;

Zhang, Ling ;

Shi, Ruihua ;

Zhen, Yanbo ;

Wang, Junping ;

Liu, Youli ;

Liao, Aijun ;

Hou, Xiaohua .

NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36

[12] Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure [J].

Sato, Naoki ;

Takahashi, Wataru ;

Hirayama, Atsushi ;

Ajioka, Masayoshi ;

Takahashi, Naoto ;

Okishige, Kaoru ;

Wang, XingLi ;

Maki, Akio ;

Maruyama, Hideki ;

Ebinger, Ursula ;

Yamaguchi, Masayuki ;

Pang, Yinuo ;

Matsumoto, Hiroki ;

Kawana, Masatoshi .

CIRCULATION JOURNAL, 2015, 79 (06) :1237-+

[13] Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial [J].

Yoshimoto, Takeshi ;

Saito, Satoshi ;

Omae, Katsuhiro ;

Tanaka, Kenta ;

Kita, Toshihiro ;

Kitamura, Kazuo ;

Fukuma, Kazuki ;

Washida, Kazuo ;

Abe, Soichiro ;

Ishiyama, Hiroyuki ;

Yamaguchi, Eriko ;

Yamagami, Hiroshi ;

Nagatsuka, Kazuyuki ;

Tsuji, Masahiro ;

Minami, Manabu ;

Yamamoto, Haruko ;

Hattori, Yorito ;

Tanaka, Tomotaka ;

Ihara, Masafumi .

ECLINICALMEDICINE, 2024, 77

[14] Double-blinded, randomized, placebo-controlled phase 2 study of FCRN antagonist batoclimab in Chinese generalized myasthenia gravis [J].

Zhao, Chongbo ;

Yan, Chong ;

Yang, Huan ;

Li, Haifeng ;

Duan, Ruisheng ;

Zou, Zhangyu ;

Zhou, Hongyu ;

Zhang, Hua ;

Lee, Michael ;

Chen, Emily ;

Chen, Xiaoxiang .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429

[15] A Randomized, Double-Blinded, Placebo-Controlled, Phase I Trial to Determine the Safety and Induction of Antibody Response of an Interleukin-1beta Vaccine in Type 2 Diabetic Patients [J].

Cavelti-Weder, Claudia ;

Timper, Katharina ;

Seelig, Eleonora ;

Keller, Cornelia ;

Osranek, Martin ;

Laessing, Ute ;

Spohn, Gunther ;

Maurer, Patrik ;

Mueller, Philipp ;

Jennings, Gary T. ;

Willers, Joerg ;

Saudan, Philippe ;

Donath, Marc Y. ;

Bachmann, Martin .

DIABETES, 2015, 64 :A282-A282

[16] Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults [J].

Che, Yanchun ;

Liu, Xiaoqiang ;

Pu, Yi ;

Zhou, Meijian ;

Zhao, Zhimei ;

Jiang, Ruiju ;

Yin, Zhifang ;

Xu, Mingjue ;

Yin, Qiongzhou ;

Wang, Jianfeng ;

Pu, Jing ;

Zhao, Heng ;

Zhang, Ying ;

Wang, Lichun ;

Jiang, Ya ;

Lei, Jin ;

Zheng, Yan ;

Liao, Yun ;

Long, Runxiang ;

Yu, Li ;

Cui, Pingfang ;

Yang, Huijuan ;

Zhang, Yuehui ;

Li, Jingyu ;

Chen, Weiwu ;

He, Zhanlong ;

Ma, Kaili ;

Hong, Chao ;

Li, Dandan ;

Jiang, Guorun ;

Liu, Donglan ;

Xu, Xingli ;

Fan, Shengtao ;

Cheng, Chen ;

Zhao, Hongling ;

Yang, Jianbo ;

Li, Yan ;

Zou, Yanxiang ;

Zhu, Youshuai ;

Zhou, Yaling ;

Guo, Yingqiu ;

Yang, Ting ;

Chen, Hongbo ;

Xie, Zhongping ;

Li, Changgui ;

Li, Qihan .

CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) :E3949-E3955

[17] Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial [J].

Lim, Jae -Sung ;

Lee, Juneyoung ;

Kang, Yeonwook ;

Park, Hyun-Tae ;

Kim, Dong-Eog ;

Cha, Jae-Kwan ;

Park, Tai Hwan ;

Heo, Jae-Hyuk ;

Lee, Kyung Bok ;

Park, Jong -Moo ;

Oh, Mi Sun ;

Kim, Eung-Gyu ;

Chang, Dae-Il ;

Heo, Sung Hyuk ;

Park, Man-Seok ;

Park, HyunYoung ;

Yi, SangHak ;

Lee, Yeong Bae ;

Park, Kwang-Yeol ;

Lee, Soo Joo ;

Kim, Jae Guk ;

Lee, Jun ;

Cho, Kyung-Hee ;

Rha, Joung-Ho ;

Kim, Yeong-In ;

Lee, Jun Hong ;

Choi, Jay Chol ;

Oh, Kyung-Mi ;

Kwon, Jee-Hyun ;

Kim, Chulho ;

Park, Jong-Ho ;

Jung, Keun-Hwa ;

Sung, Sang Min ;

Chung, Jong-Won ;

Lee, Yong-Seok ;

Kim, Hahn Young ;

Cho, Hyun-Ji ;

Park, Jeong Wook ;

Moon, Won-Jin ;

Bae, Hee-Joon .

CONTEMPORARY CLINICAL TRIALS, 2023, 126

[18] Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study [J].

Chong Yan ;

Rui-Sheng Duan ;

Huan Yang ;

Hai-Feng Li ;

Zhangyu Zou ;

Hua Zhang ;

Hongyu Zhou ;

Xiao-Li Li ;

Hao Zhou ;

Lidong Jiao ;

Jialin Chen ;

Jian Yin ;

Qin Du ;

Michael Lee ;

Yu Chen ;

Xiaoxiang Chen ;

Chongbo Zhao .

Neurology and Therapy, 2022, 11 :815-834

[19] Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study [J].

Yan, Chong ;

Duan, Rui-Sheng ;

Yang, Huan ;

Li, Hai-Feng ;

Zou, Zhangyu ;

Zhang, Hua ;

Zhou, Hongyu ;

Li, Xiao-Li ;

Zhou, Hao ;

Jiao, Lidong ;

Chen, Jialin ;

Yin, Jian ;

Du, Qin ;

Lee, Michael ;

Chen, Yu ;

Chen, Xiaoxiang ;

Zhao, Chongbo .

NEUROLOGY AND THERAPY, 2022, 11 (02) :815-834

[20] OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC) [J].

Aghajanian, C. ;

Finkler, N. J. ;

Rutherford, T. ;

Smith, D. A. ;

Yi, J. ;

Parmar, H. ;

Nycum, L. R. ;

Sovak, M. A. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)

← 1 2 3 4 5 →